Literature DB >> 2123586

Brucella suis S2, brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice.

N Bosseray1, M Plommet.   

Abstract

Live attenuated Brucella suis S2 vaccine was compared to living vaccines B. abortus S19 and B. melitensis Rev. 1 in mice. Residual virulence was estimated by ability to multiply and persist in spleen and lymph nodes. Immunogenicity was estimated by spleen counts of control and vaccinated mice challenged either with the reference B. abortus 544 strain or with virulent B. melitensis H38 and B. suis 1330 strains. S2 vaccine had lower residual virulence; expressed as 50% recovery time, persistence was 4.3 weeks, compared to 7.1 and 9.0 weeks for S19 and Rev. 1 vaccines. Immunity induced by the three vaccines was similar 45 days after vaccination. At 150 days, immunity by S19 and Rev.1 was still similar against the three challenge strains. In contrast, immunity induced by S2 had declined against the B. melitensis strain. Thus, a recall vaccination may be required for vaccination of sheep to confer a long-lasting immunity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2123586     DOI: 10.1016/0264-410x(90)90247-j

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  18 in total

1.  Temporal Role for MyD88 in a Model of Brucella-Induced Arthritis and Musculoskeletal Inflammation.

Authors:  Carolyn A Lacey; William J Mitchell; Charles R Brown; Jerod A Skyberg
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

2.  Protective efficacy and safety of Brucella melitensis 16MΔmucR against intraperitoneal and aerosol challenge in BALB/c mice.

Authors:  A M Arenas-Gamboa; A C Rice-Ficht; M M Kahl-McDonagh; T A Ficht
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

3.  Virulence criteria for Brucella abortus strains as determined by interferon regulatory factor 1-deficient mice.

Authors:  Jinkyung Ko; Annette Gendron-Fitzpatrick; Thomas A Ficht; Gary A Splitter
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

4.  Construction of Cu-Zn superoxide dismutase deletion mutants of Brucella abortus: analysis of survival in vitro in epithelial and phagocytic cells and in vivo in mice.

Authors:  F M Tatum; P G Detilleux; J M Sacks; S M Halling
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

5.  Protection against infection in mice vaccinated with a Brucella abortus mutant.

Authors:  M L Boschiroli; S L Cravero; A I Arese; E Campos; O L Rossetti
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

Review 6.  Brucellosis: the case for live, attenuated vaccines.

Authors:  Thomas A Ficht; Melissa M Kahl-McDonagh; Angela M Arenas-Gamboa; Allison C Rice-Ficht
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

7.  Enzyme-linked immunosorbent assay to differentiate the antibody responses of animals infected with Brucella species from those of animals infected with Yersinia enterocolitica O9.

Authors:  Janchivdorj Erdenebaatar; Balgan Bayarsaikhan; Masahisa Watarai; Sou-ichi Makino; Toshikazu Shirahata
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

8.  Effect of P39 gene deletion in live Brucella vaccine strains on residual virulence and protective activity in mice.

Authors:  A Tibor; I Jacques; L Guilloteau; J M Verger; M Grayon; V Wansard; J J Letesson
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

9.  Progress in Brucella vaccine development.

Authors:  Xinghong Yang; Jerod A Skyberg; Ling Cao; Beata Clapp; Theresa Thornburg; David W Pascual
Journal:  Front Biol (Beijing)       Date:  2013-02-01

10.  Bioluminescence Imaging of Colonization and Clearance Dynamics of Brucella Suis Vaccine Strain S2 in Mice and Guinea Pigs.

Authors:  Xiwen Wang; Zhiping Li; Bo Li; Hang Chi; Jiakuan Li; Hongchao Fan; Ruizhi Yao; Qianxue Li; Xiaolin Dong; Man Chen; Han Qu; Yuanyuan Wang; Weicun Gao; Yutian Wang; Yu Sun; Rui Sun; Jun Qian; Zhiping Xia
Journal:  Mol Imaging Biol       Date:  2016-08       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.